Eyenovia Inc (NASDAQ:EYEN)
| 3.16 Delayed Data As of 3:59pm ET |  +0.18 / +6.04%Today’s Change | 1.50 Today|||52-Week Range 3.34 | +93.87% Year-to-Date |
Latest EYEN News | Press Releases
No recent news for Eyenovia Inc.
Today’s Trading
| Previous close | 2.98 |
| Today’s open | 3.13 |
| Day’s range | 3.12 - 3.18 |
| Volume | 2,075 |
| Average volume (3 months) | 186,214 |
| Market cap | $108.4M |
Data as of 3:59pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +48.31% |
| Earnings growth (this year) | -78.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +600.00% |
| P/E ratio | NM |
| Price/Sales | 7.52 |
| Price/Book | 4.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DRRXDURECT Corp | -0.07 | -1.59% |
| CMRXChimerix Inc | -0.01 | -0.82% |
| TRVITrevi Therapeutics I... | -0.02 | -1.11% |
| ---- |
Data as of 3:59pm ET, 03/27/2023
Financials
| Next reporting date | March 31, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $14.0M |
| Annual profit (last year) | -$12.8M |
| Net profit margin | -91.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
